Intuitive Surgical, Inc. (ISRG)
USD 526.47
(-3.43%)
USD 526.47
(-3.43%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 4.72 Billion USD | 12.71% |
| 2022 | 4.19 Billion USD | 6.0% |
| 2021 | 3.95 Billion USD | 38.35% |
| 2020 | 2.86 Billion USD | -8.01% |
| 2019 | 3.11 Billion USD | 19.43% |
| 2018 | 2.6 Billion USD | 18.69% |
| 2017 | 2.19 Billion USD | 16.08% |
| 2016 | 1.89 Billion USD | 19.79% |
| 2015 | 1.57 Billion USD | 11.61% |
| 2014 | 1.41 Billion USD | -11.32% |
| 2013 | 1.59 Billion USD | 1.52% |
| 2012 | 1.57 Billion USD | 23.28% |
| 2011 | 1.27 Billion USD | 23.67% |
| 2010 | 1.03 Billion USD | 37.14% |
| 2009 | 751.05 Million USD | 20.99% |
| 2008 | 620.77 Million USD | 49.84% |
| 2007 | 414.28 Million USD | 67.16% |
| 2006 | 247.83 Million USD | 61.38% |
| 2005 | 153.56 Million USD | 74.53% |
| 2004 | 87.99 Million USD | 99.85% |
| 2003 | 44.02 Million USD | 17.61% |
| 2002 | 37.43 Million USD | 59.62% |
| 2001 | 23.45 Million USD | 75.76% |
| 2000 | 13.34 Million USD | 322.04% |
| 1999 | 3.16 Million USD | 0.0% |
| 1998 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 1.37 Billion USD | 0.09% |
| 2024 Q1 | 1.24 Billion USD | -2.51% |
| 2024 Q2 | 1.37 Billion USD | 10.22% |
| 2023 FY | 4.72 Billion USD | 12.71% |
| 2023 Q3 | 1.16 Billion USD | -0.4% |
| 2023 Q4 | 1.27 Billion USD | 9.44% |
| 2023 Q2 | 1.17 Billion USD | 5.29% |
| 2023 Q1 | 1.11 Billion USD | 0.19% |
| 2022 Q4 | 1.11 Billion USD | 5.59% |
| 2022 Q2 | 1.02 Billion USD | 1.35% |
| 2022 Q1 | 1 Billion USD | -4.82% |
| 2022 FY | 4.19 Billion USD | 6.0% |
| 2022 Q3 | 1.05 Billion USD | 2.81% |
| 2021 Q1 | 902.6 Million USD | 0.76% |
| 2021 Q2 | 1.02 Billion USD | 13.42% |
| 2021 Q3 | 971.4 Million USD | -5.11% |
| 2021 Q4 | 1.06 Billion USD | 9.2% |
| 2021 FY | 3.95 Billion USD | 38.35% |
| 2020 Q3 | 724.3 Million USD | 44.02% |
| 2020 Q1 | 738.2 Million USD | -17.61% |
| 2020 Q2 | 502.9 Million USD | -31.87% |
| 2020 FY | 2.86 Billion USD | -8.01% |
| 2020 Q4 | 895.8 Million USD | 23.68% |
| 2019 Q2 | 759 Million USD | 13.35% |
| 2019 FY | 3.11 Billion USD | 19.43% |
| 2019 Q1 | 669.6 Million USD | -8.98% |
| 2019 Q4 | 896 Million USD | 14.05% |
| 2019 Q3 | 785.6 Million USD | 3.5% |
| 2018 Q3 | 642.3 Million USD | 1.58% |
| 2018 Q1 | 593.8 Million USD | -6.24% |
| 2018 Q2 | 632.3 Million USD | 6.48% |
| 2018 FY | 2.6 Billion USD | 18.69% |
| 2018 Q4 | 735.7 Million USD | 14.54% |
| 2017 Q2 | 527.9 Million USD | 13.26% |
| 2017 FY | 2.19 Billion USD | 16.08% |
| 2017 Q4 | 633.3 Million USD | 11.73% |
| 2017 Q3 | 566.8 Million USD | 7.37% |
| 2017 Q1 | 466.1 Million USD | -11.59% |
| 2016 Q2 | 470.9 Million USD | 16.27% |
| 2016 Q1 | 405 Million USD | -11.73% |
| 2016 Q4 | 527.2 Million USD | 8.25% |
| 2016 FY | 1.89 Billion USD | 19.79% |
| 2016 Q3 | 487 Million USD | 3.42% |
| 2015 Q1 | 336.8 Million USD | -14.39% |
| 2015 Q4 | 458.8 Million USD | 15.92% |
| 2015 Q3 | 395.8 Million USD | 2.41% |
| 2015 FY | 1.57 Billion USD | 11.61% |
| 2015 Q2 | 386.5 Million USD | 14.76% |
| 2014 Q3 | 360.6 Million USD | 4.7% |
| 2014 FY | 1.41 Billion USD | -11.32% |
| 2014 Q1 | 315.4 Million USD | -20.75% |
| 2014 Q2 | 344.4 Million USD | 9.19% |
| 2014 Q4 | 393.4 Million USD | 9.1% |
| 2013 FY | 1.59 Billion USD | 1.52% |
| 2013 Q3 | 356.7 Million USD | -11.97% |
| 2013 Q4 | 398 Million USD | 11.58% |
| 2013 Q2 | 405.2 Million USD | -6.7% |
| 2013 Q1 | 434.3 Million USD | -0.82% |
| 2012 Q3 | 390.1 Million USD | 0.96% |
| 2012 Q4 | 437.9 Million USD | 12.25% |
| 2012 FY | 1.57 Billion USD | 23.28% |
| 2012 Q2 | 386.4 Million USD | 8.57% |
| 2012 Q1 | 355.9 Million USD | -1.93% |
| 2011 Q1 | 278.8 Million USD | -1.17% |
| 2011 FY | 1.27 Billion USD | 23.67% |
| 2011 Q2 | 306.6 Million USD | 9.97% |
| 2011 Q3 | 325.5 Million USD | 6.16% |
| 2011 Q4 | 362.9 Million USD | 11.49% |
| 2010 FY | 1.03 Billion USD | 37.14% |
| 2010 Q1 | 240.5 Million USD | 3.15% |
| 2010 Q3 | 250.6 Million USD | -2.41% |
| 2010 Q4 | 282.1 Million USD | 12.57% |
| 2010 Q2 | 256.8 Million USD | 6.78% |
| 2009 Q3 | 199 Million USD | 4.64% |
| 2009 Q1 | 128.7 Million USD | -22.16% |
| 2009 FY | 751.05 Million USD | 20.99% |
| 2009 Q2 | 190.18 Million USD | 47.77% |
| 2009 Q4 | 233.15 Million USD | 17.16% |
| 2008 Q2 | 156.05 Million USD | 20.22% |
| 2008 Q4 | 165.34 Million USD | -2.5% |
| 2008 Q3 | 169.57 Million USD | 8.66% |
| 2008 Q1 | 129.8 Million USD | -3.99% |
| 2008 FY | 620.77 Million USD | 49.84% |
| 2007 Q4 | 135.2 Million USD | 24.64% |
| 2007 Q1 | 76.5 Million USD | 2.09% |
| 2007 FY | 414.28 Million USD | 67.16% |
| 2007 Q2 | 94.1 Million USD | 23.0% |
| 2007 Q3 | 108.47 Million USD | 15.26% |
| 2006 Q3 | 62.23 Million USD | 5.52% |
| 2006 FY | 247.83 Million USD | 61.38% |
| 2006 Q1 | 51.68 Million USD | 6.42% |
| 2006 Q2 | 58.97 Million USD | 14.12% |
| 2006 Q4 | 74.94 Million USD | 20.43% |
| 2005 FY | 153.56 Million USD | 74.53% |
| 2005 Q1 | 27.26 Million USD | -8.53% |
| 2005 Q2 | 35.62 Million USD | 30.68% |
| 2005 Q3 | 42.11 Million USD | 18.22% |
| 2005 Q4 | 48.56 Million USD | 15.3% |
| 2004 Q4 | 29.8 Million USD | 31.17% |
| 2004 Q3 | 22.72 Million USD | 15.76% |
| 2004 FY | 87.99 Million USD | 99.85% |
| 2004 Q2 | 19.62 Million USD | 23.95% |
| 2004 Q1 | 15.83 Million USD | 126.26% |
| 2003 Q4 | 6.99 Million USD | -46.1% |
| 2003 Q3 | 12.98 Million USD | -4.14% |
| 2003 FY | 44.02 Million USD | 17.61% |
| 2003 Q1 | 10.49 Million USD | -9.77% |
| 2003 Q2 | 13.54 Million USD | 29.06% |
| 2002 Q4 | 11.63 Million USD | 33.09% |
| 2002 FY | 37.43 Million USD | 59.62% |
| 2002 Q3 | 8.74 Million USD | -13.98% |
| 2002 Q2 | 10.16 Million USD | 47.23% |
| 2002 Q1 | 6.9 Million USD | 1.99% |
| 2001 Q1 | 5.94 Million USD | 23.04% |
| 2001 Q4 | 6.76 Million USD | 32.4% |
| 2001 FY | 23.45 Million USD | 75.76% |
| 2001 Q3 | 5.11 Million USD | -15.67% |
| 2001 Q2 | 6.06 Million USD | 1.97% |
| 2000 Q3 | 4.49 Million USD | 55.56% |
| 2000 Q1 | 1.13 Million USD | 0.0% |
| 2000 FY | 13.34 Million USD | 322.04% |
| 2000 Q4 | 4.83 Million USD | 7.5% |
| 2000 Q2 | 2.88 Million USD | 155.21% |
| 1999 FY | 3.16 Million USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 56.3 Million USD | -8299.787% |
| AngioDynamics, Inc. | 154.69 Million USD | -2957.247% |
| AtriCure, Inc. | 300.37 Million USD | -1474.558% |
| Avinger, Inc. | 2 Million USD | -236020.819% |
| Azenta, Inc. | 263.14 Million USD | -1697.332% |
| BioLife Solutions, Inc. | 46.75 Million USD | -10016.145% |
| The Cooper Companies, Inc. | 2.35 Billion USD | -100.581% |
| Daxor Corporation | 1.1 Million USD | -428514.152% |
| Ekso Bionics Holdings, Inc. | 9.07 Million USD | -51992.741% |
| Femasys Inc. | 691.9 Thousand USD | -683451.549% |
| GlucoTrack, Inc. | -13 Thousand USD | 36380869.231% |
| Harvard Bioscience, Inc. | 60.86 Million USD | -7670.348% |
| Hologic, Inc. | 2.22 Billion USD | -112.295% |
| ICU Medical, Inc. | 739.87 Million USD | -539.231% |
| KORU Medical Systems, Inc. | 16.7 Million USD | -28206.321% |
| LeMaitre Vascular, Inc. | 127.04 Million USD | -3622.579% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 3963512.079% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 3963512.079% |
| Masimo Corporation | 1 Billion USD | -371.3% |
| Microbot Medical Inc. | -106 Thousand USD | 4461892.453% |
| Meihua International Medical Technologies Co., Ltd. | 33.09 Million USD | -14190.677% |
| Merit Medical Systems, Inc. | 583.87 Million USD | -710.023% |
| Nephros, Inc. | 8.4 Million USD | -56170.077% |
| NovoCure Limited | 381.05 Million USD | -1141.15% |
| NEXGEL, Inc. | 619 Thousand USD | -763954.927% |
| NEXGEL, Inc. | 619 Thousand USD | -763954.927% |
| Singular Genomics Systems, Inc. | -558 Thousand USD | 847680.645% |
| OraSure Technologies, Inc. | 179.42 Million USD | -2535.979% |
| Pro-Dex, Inc. | 14.55 Million USD | -32402.921% |
| Pulse Biosciences, Inc. | -1.2 Million USD | 391939.271% |
| Predictive Oncology Inc. | 1.14 Million USD | -412849.654% |
| Precision Optics Corporation, Inc. | 5.79 Million USD | -81474.369% |
| QuidelOrtho Corporation | 1.49 Billion USD | -216.482% |
| Repligen Corporation | 315.22 Million USD | -1400.343% |
| Sanara MedTech Inc. | 57.13 Million USD | -8177.451% |
| STAAR Surgical Company | 252.65 Million USD | -1771.95% |
| Sharps Technology, Inc. | -891.24 Thousand USD | 530760.377% |
| Utah Medical Products, Inc. | 30.03 Million USD | -15645.056% |
| DENTSPLY SIRONA Inc. | 2.08 Billion USD | -126.726% |
| Jin Medical International Ltd. | 6.78 Million USD | -69606.938% |